HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management

M Lechner, J Liu, L Masterson, TR Fenton - Nature reviews Clinical …, 2022 - nature.com
Abstract Human papillomavirus (HPV)-positive (HPV+) oropharyngeal squamous cell
carcinoma (OPSCC) has one of the most rapidly increasing incidences of any cancer in high …

Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno …

S Hendry, R Salgado, T Gevaert… - Advances in anatomic …, 2017 - journals.lww.com
Assessment of the immune response to tumors is growing in importance as the prognostic
implications of this response are increasingly recognized, and as immunotherapies are …

Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments

B Solomon, RJ Young, D Rischin - Seminars in cancer biology, 2018 - Elsevier
Head and neck squamous cell carcinoma (HNSCC) comprises a heterogeneous group of
tumors that arise from the squamous epithelium of the oral cavity, oropharynx, larynx and …

HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer

TA Barnes, E Amir - British journal of cancer, 2017 - nature.com
Interactions between immune and malignant cells have been known to have clinical
relevance for decades. The potential for immune control is now being therapeutically …

Assessing the interactions between radiotherapy and antitumour immunity

C Grassberger, SG Ellsworth, MQ Wilks… - Nature reviews Clinical …, 2019 - nature.com
Immunotherapy, specifically the introduction of immune checkpoint inhibitors, has
transformed the treatment of cancer, enabling long-term tumour control even in individuals …

Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation and regulatory T-cell infiltration

A Oweida, MK Hararah, A Phan, D Binder, S Bhatia… - Clinical Cancer …, 2018 - AACR
Purpose: Radiotherapy (RT) can transform the immune landscape and render poorly
immunogenic tumors sensitive to PD-L1 inhibition. Here, we established that the response to …

Hypoxia compromises anti-cancer immune responses

G Multhoff, P Vaupel - Oxygen transport to tissue XLI, 2020 - Springer
Hypoxia, one of the hallmarks of cancer, is caused by an insufficient oxygen supply, mostly
due to a chaotic, deficient tumor microcirculation. Apart from a hypoxia-mediated resistance …

Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting

P Economopoulou, R De Bree, I Kotsantis… - Frontiers in …, 2019 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) represents a group of tumors arising in
the oral cavity, oropharynx, and larynx. Although HNSCC is traditionally associated with …

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients

HR Kim, SJ Ha, MH Hong, SJ Heo, YW Koh, EC Choi… - Scientific reports, 2016 - nature.com
To investigate the expression of programmed death-ligand 1 (PD-L1) and immune
checkpoints and their prognostic value for resected head and neck squamous cell cancer …

Head and neck cancer: improving outcomes with a multidisciplinary approach

C Lo Nigro, N Denaro, A Merlotti… - Cancer management and …, 2017 - Taylor & Francis
For early-stage head and neck cancer (HNC), surgery (S) or radiotherapy (RT) is a standard
treatment. The multidisciplinary approach, which includes multimodality treatment with S …